Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers

Diabetes Care. 1994 Apr;17(4):322-5. doi: 10.2337/diacare.17.4.322.

Abstract

Objective: To evaluate the utility of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers.

Research design and methods: Nineteen subjects with either insulin-dependent diabetes mellitus (IDDM) or non-insulin-dependent diabetes mellitus (NIDDM) and foot ulcers were randomly assigned to the polymeric dressing or conventional wet-to-dry saline dressings. Subjects had foot ulcer site measurements performed every 3 weeks. The subjects using conventional therapy were allowed to cross over to polymeric dressing after 2 months.

Results: At the end of 2 months, in the patients using the polymeric dressing, ulcer size was reduced to 35 +/- 16% of baseline. The patients on conventional therapy had an ulcer size of 105 +/- 28% of baseline (P < 0.03, polymeric vs. conventional). Patients initially treated with wet-to-dry saline were crossed over into the polymeric membrane treatment and demonstrated a decrease to 35 +/- 11% of baseline size (p < 0.02) after an additional 2 months.

Conclusions: The semipermeable polymeric membrane dressing is a useful therapeutic option for treating uncomplicated chronic diabetic foot ulcers.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chronic Disease
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetic Foot / therapy*
  • Female
  • Glycerol*
  • Humans
  • Male
  • Middle Aged
  • Polyurethanes*
  • Prospective Studies
  • Surface-Active Agents*
  • Wound Healing

Substances

  • Polymem
  • Polyurethanes
  • Surface-Active Agents
  • Glycerol